TY  - RPRT
TI  - Prognostic Value of Blood-Based P-Tau217 Levels for Progression to Cognitive Impairment.
AU  - Rachel F Buckley
AU  - Diana L Townsend
AU  - Colin J Birkenbihl
AU  - Madison Cuppels
AU  - Gillian T Coughlan
AU  - Mabel T Seto
AU  - Jane A Brown
AU  - Michael J Properzi
AU  - Merle C Hönig
AU  - Annie Li
AU  - Aaron P Schultz
AU  - Jasmeer Chhatwal
AU  - Hyun-Sik Yang
AU  - Steven Arnold
AU  - Pia Kivisäkk
AU  - Bryan D James
AU  - Sid O'Bryant
AU  - Robert A Rissman
AU  - Melissa Petersen
AU  - Jessica Z K Caldwell
AU  - Tobey Betthauser
AU  - Julie Elisabeth Oomens
AU  - Maria Carrigan
AU  - Brian Healy
AU  - Jorge Garcia Condado
AU  - Sterling C Johnson
AU  - Wai-Ying Wendy Yau
AU  - Oliver Langford
AU  - Michelle Farrell
AU  - Rebecca E Amariglio
AU  - Dorene M Rentz
AU  - Kathryn V Papp
AU  - Ron Brookmeyer
AU  - Timothy J Hohman
AU  - Michael Donohue
AU  - Paul S Aisen
AU  - Keith A Johnson
AU  - Reisa A Sperling
AU  - Alzheimer’s Disease Neuroimaging Initiative, Anti-Amyloid Treatment in Asymptomatic Alzheimer’s (A4) and Longitudinal Evaluation of Amyloid Risk and Neurodegeneration (LEARN) studies, Harvard Aging Brain Study (HABS), Health & Aging Brain Study – Health D
AU  - Alzheimer’s Disease Neuroimaging Initiative, Anti-Amyloid Treatment in Asymptomatic Alzheimer’s (A4) and Longitudinal Evaluation of Amyloid Risk and Neurodegeneration (LEARN) studies, Harvard Aging Brain Study (HABS), Health & Aging Brain Study – Health Disparities (HABS-HD), and Wisconsin Registry for Alzheimer’s Prevention (WRAP)
PY  - 2026
DO  - 10.1001/jama.2026.12556
UR  - https://pubmed.ncbi.nlm.nih.gov/42449500/
ID  - 42449500
ER  -